Jaguar Health, Inc.
Price Action
Technical Summary
DOWNTRENDJaguar Health, Inc. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 1), showing significant lag compared to the market leaders. Earnings growth of 90% provides fundamental context to the price action. However, RSI is deeply oversold at 17, suggesting potential for a mean-reversion bounce.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $10.83 | -73.96% | BELOW |
| 50 SMA | $15.11 | -81.33% | BELOW |
| 100 SMA | $22.86 | -87.66% | BELOW |
| 150 SMA | $35.63 | -92.09% | BELOW |
| 200 SMA | $44.44 | -93.65% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is JAGX in an uptrend right now?
JAGX has a trend score of 0/4 based on Minervini's Stage Analysis. Currently showing broken structure - 0 of 4 trend criteria are met.
Is JAGX overbought or oversold?
JAGX's RSI (14) is 17. The stock is oversold (RSI < 30), which could indicate a bounce opportunity.
Is JAGX outperforming the market?
JAGX has a Relative Strength (RS) Rating of 1 out of 99. JAGX is currently lagging the broader market.
Where is JAGX in its 52-week range?
JAGX is trading at $2.82, which is 1% of its 52-week high ($423.15) and 1% above its 52-week low ($0.71).
How volatile is JAGX?
JAGX has a Beta of 2.72 and 52-week volatility of 176%. It's more volatile than the S&P 500 - expect bigger swings.